Kepos Capital LP Enanta Pharmaceuticals Inc Transaction History

Kepos Capital LP

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2020 May 12, 2020	SELL	$40.22 - $62.0 $529,456 - $816,168	-13,164 Closed	0 $0
Q3 2019 Nov 13, 2019	SELL	$60.08 - $88.17 $410,466 - $602,377	-6,832 Reduced 34.17%	13,164 $791,000
Q3 2018 Nov 13, 2018	BUY	$85.46 - $126.37 $1.71 Million - $2.53 Million	19,996 New	19,996 $1.71 Million

110

21.1M

4.8K

4.6K

Ticker ENTA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 20,724,900
Market Cap $126M
Description
Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...

Get notified when there are updates to the investment portfolio of Kepos Capital LP, based on Form 13F filings with the SEC.

Stay updated on Kepos Capital LP with notifications on news.